Dow Drops Over 500 Points for 4th-Straight Loss
Stocks fell sharply today, brushing off more encouraging inflation data as the market succumbed to trade policy...
loss
Amgen weight loss drug MariTide starts two phase three trials
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17,...
Eli Lilly offering more cheaper vials of Zepbound weight loss drug
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York...
Eli Lilly Dan Skovronsky discusses weight loss drugs
Dan Skovronsky knows what makes a good obesity drug. As chief scientific officer at Eli...
Eli Lilly to release data on weight loss drug retatrutide in 2025
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in...
Fintech GoCardless halves loss, targets full-year profit by 2026
Hiroki Takeuchi, co-founder and CEO of GoCardless. Zed Jameson | Bloomberg | Getty Images Financial...
This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?
Medications known as glucagon-like peptide 1 (GLP-1) receptor agonists are taking over the healthcare industry....
Nvidia rises 2% in tenuous bounce Tuesday following largest market value loss in history
Jen-Hsun Huang, chief executive officer of Nvidia Corp. Patrick T. Fallon | Bloomberg | Getty...
Boeing expects $4 billion loss for fourth quarter after chaotic 2024
An aerial view of the engines and fuselage of an unpainted Boeing 737 MAX airplane...
Eli Lilly LLY cuts 2024 revenue outlook on weight loss drugs
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in...
